TREMFYA

Concentrate for solution for infusion, 200mg
RxActive license

Active substance (INN)

guselkumab

Pharmaceutical form

Pharmaceutical formConcentrate for solution for infusion
Strength200mg
PackagingUkupno 1 bočica staklena sa 20ml koncentrata za rastvor za infuziju u kartonskoj kutiji
ManufacturerJanssen Biologics B.V., Netherlands
Therapeutic groupAntineoplastic and immunomodulating agents (L04AC16)
Marketing authorization holderDRUŠTVO ZA TRGOVINU NA VELIKO FARMACEUTSKIM PROIZVODIMA "GLOSARIJ" D.O.O.-PODGORICA
Authorization dateFebruary 24, 2026

Analogs in Montenegro

3

Other medicines with the same active substance

TREMFYARx
Solution for injection in pre-filled pen, 200mgJanssen Biologics B.V.
TREMFYARx
Solution for injection in pre-filled syringe, 100mgJanssen Biologics B.V.
TREMFYARx
Solution for injection in pre-filled syringe, 200mgJanssen Biologics B.V.
Source: CInMED register